Kateryna Pantiukh

Kateryna Pantiukh

Auto-generated profile, based on publicly available information

Kateryna Pantiukh

Estonian Genome Centre, Institute of Genomics, University of Tartu

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 July 2024 in Gut Microbes
Verified
Journal Article
Open access
KKKertu Liis Krigul
Kertu Liis Krigul
RFRachel H. Feeney
Rachel H. Feeney
SWSupapit Wongkuna
Supapit Wongkuna
OAOliver Aasmets
Oliver Aasmets
SHSandra M. Holmberg
Sandra M. Holmberg
BSBjoern O. Schroeder
Bjoern O. Schroeder
Recent evidence indicates that repeated antibiotic usage lowers microbial diversity and ultimately changes the gut microbiota community. However, the physiological effects of repeated - but not recent - antibiotic usage on microbiota-mediated mucosal barrier function are largely unknown. By selecting human individuals from the deeply phenotyped Estonian Microbiome Cohort (EstMB), we here utilized human-to-mouse fecal microbiota transplantation to explore long-term impacts of repeated antibiotic use on intestinal mucus function. While a healthy mucus layer protects the intestinal epithelium against infection and inflammation, using ex vivo mucus function analyses of viable colonic tissue explants, we show that microbiota from humans with a history of repeated antibiotic use causes reduced mucus growth rate and increased mucus penetrability compared to healthy controls in the transplanted mice. Moreover, shotgun metagenomic sequencing identified a significantly altered microbiota composition in the antibiotic-shaped microbial community, with known mucus-utilizing bacteria, including Akkermansia muciniphila and Bacteroides fragilis, dominating in the gut. The altered microbiota composition was further characterized by a distinct metabolite profile, which may be caused by differential mucus degradation capacity. Consequently, our proof-of-concept study suggests that long-term antibiotic use in humans can result in an altered microbial community that has reduced capacity to maintain proper mucus function in the gut.

9 July 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
KPKateryna Pantiukh
Kateryna Pantiukh
OAOliver Aasmets
Oliver Aasmets
KKKertu Liis Krigul
Kertu Liis Krigul
EOElin Org
Elin Org
Metagenomic profiling has advanced understanding of microbe-host interactions. However, widely used read-based approaches are limited by incomplete reference databases and the inability to resolve strain-level variation. Here, we present a scalable, genome-resolved framework that integrates population-specific metagenome assembled genomes (MAGs) to discover novel species, sub-species diversity, and disease associations. From 1,878 deeply sequenced samples in the Estonian microbiome cohort (EstMB-deep), we reconstructed 84,762 MAGs representing 2,257 species, including 353 (15.6%) previously uncharacterized species reaching up to 30% relative abundances in some individuals. We integrated these MAGs with the Unified Human Gastrointestinal Genome (UHGG) collection to create an expanded reference (GUTrep), enabling profiling of 2,509 EstMB individuals and testing associations with 33 prevalent diseases. Of 25 diseases with significant associations, 8 involved newly identified species, underscoring the value of population-specific MAGs. To quantify within-species diversity, we developed the Genome Unit Number (GUN), a novel MAG-based metric that informed sub-species analyses. Based on normalized GUN (nGUN), we prioritized Odoribacter splanchnicus, a prevalent species with the lowest sub-species heterogeneity, yielding sufficient power for sub-species association study. We identified two dominant genome units, GU-N1 and GU-N2, with distinct gene repertoires and divergent disease associations. Notably, GU-N1 was negatively associated with gastritis and duodenitis and hypertensive heart disease, associations undetected at the species level. Our study expands the human gut reference landscape, demonstrates the importance of population-specific MAGs for uncovering novel microbial diversity, and reveals new disease associations on sub-species level obscured at higher taxonomic levels, highlighting the need for genome-resolved approaches in microbiome research. IMPORTANCE: Microbiome studies increasingly recognize that species-level profiles can mask critical sub-species differences relevant to health and disease. However, our work shows that within-species diversity varies drastically across gut microbes, with some species exhibiting almost as many distinct sub-species clusters as recovered genomes, making association studies at the sub-species level essentially intractable. To address this, we introduce the Genome Unit Number (GUN), a scalable metric for quantifying sub-species structure. Using GUN, we demonstrate that only species with limited within-species diversity, such as Odoribacter splanchnicus , currently allow for robust sub-species association testing. These findings emphasize the need to systematically evaluate species structure across the gut microbiome and call for the development of new computational and statistical approaches to enable meaningful sub-species analyses in highly diverse species.

22 April 2016 in F1000Research
Verified
Journal Article
Open access
PDF file
KPKateryna S. Pantiukh
Kateryna S. Pantiukh
NCNikolay Chekanov
Nikolay Chekanov
IZIgor Zaigrin
Igor Zaigrin
AZAlexei M. Zotov
Alexei M. Zotov
AMAlexander M. Mazur
Alexander M. Mazur
EPEgor B. Prokhortchouk
Egor B. Prokhortchouk
Concerns of traditional prenatal aneuploidy testing methods, such as low accuracy of noninvasive and health risks associated with invasive procedures, were overcome with the introduction of novel noninvasive methods based on genetics (NIPT). These were rapidly adopted into clinical practice in many countries after a series of successful trials of various independent submethods. Here we present results of own NIPT trial carried out in Moscow, Russia. 1012 samples were subjected to the method aimed at measuring chromosome coverage by massive parallel sequencing. Two alternative approaches are ascertained: one based on maternal/fetal differential methylation and another based on allelic difference. While the former failed to provide stable results, the latter was found to be promising and worthy of conducting a large-scale trial. One critical point in any NIPT approach is the determination of fetal cell-free DNA fraction, which dictates the reliability of obtained results for a given sample. We show that two different chromosome Y representation measures-by real-time PCR and by whole-genome massive parallel sequencing-are practically interchangeable (r=0.94). We also propose a novel method based on maternal/fetal allelic difference which is applicable in pregnancies with fetuses of either sex. Even in its pilot form it correlates well with chromosome Y coverage estimates (r=0.74) and can be further improved by increasing the number of polymorphisms.

7 March 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
KKKertu Liis Krigul
Kertu Liis Krigul
RFRachel H. Feeney
Rachel H. Feeney
SWSupapit Wongkuna
Supapit Wongkuna
OAOliver Aasmets
Oliver Aasmets
SHSandra M. Holmberg
Sandra M. Holmberg
BSBjoern O. Schroeder
Bjoern O. Schroeder
Recent evidence indicates that repeated antibiotic usage lowers microbial diversity and lastingly changes the gut microbiota community. However, the physiological effects of repeated – but not recent – antibiotic usage on microbiota-mediated mucosal barrier function are largely unknown. By selecting human individuals from the deeply-phenotyped Estonian Microbiome Cohort (EstMB) we here utilised human-to-mouse faecal microbiota transplantation to explore long-term impacts of repeated antibiotic use on intestinal mucus function. While a healthy mucus layer protects the intestinal epithelium against infection and inflammation, using ex-vivo mucus function analyses of viable colonic tissue explants, we show that microbiota from humans with a history of repeated antibiotic use causes reduced mucus growth rate and increased mucus penetrability compared to healthy controls in the transplanted mice. Moreover, shotgun metagenomic sequencing identified a significantly altered microbiota composition in the antibiotic-shaped microbial community, with known mucus-utilising bacteria, including Akkermansia muciniphila and Bacteroides fragilis , dominating in the gut. The altered microbiota composition was further characterised by a distinct metabolite profile, which may be caused by differential mucus degradation capacity. Consequently, our findings suggest that long-term antibiotic use in humans results in an altered microbial community that has reduced capacity to maintain proper mucus function in the gut.

7 July 2019 in Vavilov Journal of Genetics and Breeding
Verified
Journal Article
Open access
PDF file
KPK. S. Pantiukh
K. S. Pantiukh
IRI. V. Rukin
I. V. Rukin
SPS. V. Portnov
S. V. Portnov
AKA. Khatib
A. Khatib
SPS. V. Panteleev
S. V. Panteleev
АХА. Хатиб
А. Хатиб
The integration of high technologies into livestock production has been actively occurring in the last decade in the countries with a developed animal breeding. First of all, we are talking about reproductive technologies (IVF) and genomic technologies (general genomic evaluation of animal and genomic evaluation of breeding value). Combining reproductive and genomic technologies is a promising approach that allows receiving highquality breeding cattle in the shortest possible time. The basis of the proposed technology for accelerated reproduction of high-value breeding cattle is to obtain information about the genome of the embryo for genomic evaluation. The amount of genetic material that can be obtained for research is extremely limited, as it is necessary to preserve the viability of the embryo. The stage of the whole genome amplification was introduced to obtain a high quality of genetic material in a sufficient quantity. The main purpose of this work is to assess the possibility of using embryo biopsy specimens (bsp) for embryo genotyping using microarray chips and predicting the carrier status of lethal haplotypes at the embryo stage. We obtained 100 cattle embryos, of which 78 biopsy specimens were taken to analysis. For the biopsies obtained we performed the whole genome amplification. The quality and quantity of DNA for all the 78 samples after the whole genome amplification were satisfactory for further genotyping. The quality of the performed genotyping was satisfactory and allowed the assessment of lethal haplotype carriers (determining the sex of the animal and identification of the carrier status for sevenHolsteinlethal haplotypes). We tested 78 embryos. From the genotyping analysis, there was detected one carrier status for three lethal haplotypes, HH0 (Brachyspina), HH5, and HCD. The carrier status of HH0 and HH5 was confirmed by testing the casual mutation using PCR analysis. The carrier status for HCD has not been confirmed by casual mutation analysis. The situation in which an animal is an HCD carrier, but not the carrier of a casual mutation, can be explained. The putative ancestor of the haplotype is the bull HOCAN000000334489 WILLOWHOLME MARK ANTHONY (year of birth is 1975), but a casual mutation associated with this disease has arisen only in his descendant HOCAN000005457798 MAUGHLIN STORM (year of birth is 1991). The results obtained confirm the importance of testing the casual mutation in the animals that are carriers of lethal haplotypes according to the genotyping data.

23 June 2026 in mSystems
Verified
Journal Article
Open access
KZKinga Zielińska
Kinga Zielińska
KPKateryna Pantiukh
Kateryna Pantiukh
EOElin Org
Elin Org
PLPawel Labaj
Pawel Labaj
TKTomasz Kosciolek
Tomasz Kosciolek
Next-generation sequencing has revolutionized microbiome research, yet the transition from taxonomic to functional profiling remains a major technical challenge. While marker gene sequencing provides a widely accessible ecological view, it often lacks the resolution for actionable insights. This perspective argues that shifting to whole metagenomic sequencing is essential for mapping functional potential, such as antimicrobial resistance, and metabolic pathways. However, we identify a critical bottleneck: excessive multiplexing. High multiplexing ratios reduce the number of unique molecules per sample, leading to high duplication rates and the stochastic dropout of low-abundance genes. We demonstrate that functional profiles are far more sensitive to these library complexity issues than taxonomic ones. We recommend prioritizing total sequencing depth and reducing multiplexing to ensure sufficient unique coverage. Additionally, adopting long-read or hybrid architectures is vital for providing the genomic context necessary for strain-level resolution. These optimizations are prerequisites for robust global microbiome synthesis and translational science.